Added by | mollevi |
---|---|
Group name | EquipeMY |
Item Type | Attachment |
Title | PubMed entry |
URL | http://www.ncbi.nlm.nih.gov/pubmed/30798084 |
Accessed | 2019/03/14 - 13:50:07 |
Date Added | 2019/03/14 - 12:50:07 |
Date Modified | 2019/03/14 - 12:50:07 |
Parent item | Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS) |